Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does early erythropoietin therapy decrease transfusions in anemia of prematurity?

Begüm Atasay1, Ayla Günlemez, Nejat Akar

  • 1Department of Neonatology and Molecular Pathology, Ankara University, Turkey. arsanm@superonline.com

Indian Journal of Pediatrics
|June 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal Intestinal Perforations Due to IL10RB Deficiency.

Indian journal of pediatrics·2026
Same author

Clinical Utility of the Syndromic Meningitis/Encephalitis Molecular Panel in Neonates with Suspected Sepsis.

Zeitschrift fur Geburtshilfe und Neonatologie·2026
Same author

Development and validation of a GC-MS method for the simultaneous determination of bisphenols, phthalate monoesters, and triclosan in human meconium for comprehensive prenatal exposure assessment.

Journal of pharmaceutical and biomedical analysis·2026
Same author

Hyperkalemia in the neonatal intensive care unit: actual or pseudohyperkalemia?

Postgraduate medicine·2025
Same author

Feasibility and early outcomes of intact cord resuscitation without special equipment in extremely preterm infants born at 23-25 weeks of gestation: A case series.

European journal of pediatrics·2025
Same author

Potential Association Between Nonketotic Hyperglycinemia and Extensive Mongolian Spots: A Novel Dermatological Observation-Case Report.

Journal of paediatrics and child health·2025

Early erythropoietin and iron therapy did not significantly reduce transfusion needs in very low birth weight infants. Phlebotomy losses in neonatal intensive care units remain a challenge, limiting the effectiveness of this treatment.

Area of Science:

  • Neonatalogy
  • Pediatric Hematology
  • Pharmacology

Background:

  • Very Low Birth Weight (VLBW) infants often require interventions for acute neonatal problems.
  • Erythropoiesis induction is crucial for managing anemia in premature infants.
  • The role of early erythropoietin treatment in VLBW infants is under investigation.

Purpose of the Study:

  • To evaluate the impact of early erythropoietin and iron supplementation on erythropoiesis and transfusion requirements in VLBW infants.
  • To assess the efficacy of subcutaneous erythropoietin (600 U/kg/week) and oral iron (3 mg/kg/day) in this population.

Main Methods:

  • A randomized controlled trial involving 14 VLBW infants receiving erythropoietin and iron, and 13 VLBW infants receiving placebo.
  • Weekly monitoring of hematocrit, reticulocyte counts, and blood volumes for phlebotomy and transfusions.

Related Experiment Videos

  • Study duration was the first 7-8 weeks of life.

    • Main Results:

    • No significant differences were observed in hematocrit, reticulocyte, or ferritin levels between the groups at therapy completion.
    • While the study group had higher blood draw volumes and lower transfusion volumes, these differences were not statistically significant (p>0.05).
    • Comparable birth weights and gestational ages were noted between the groups.

    Conclusions:

    • Early erythropoietin and iron therapy, at the studied doses, were ineffective in reducing transfusion needs in VLBW infants.
    • High phlebotomy losses in neonatal intensive care units, particularly in developing countries, limit the potential benefits of such therapies.
    • Further research may be needed to optimize treatment protocols or explore alternative strategies for anemia management in VLBW infants.